PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32325339-0	2020	Exploiting oxadiazole-sulfonamide hybrids as new structural leads to combat diabetic complications via aldose reductase inhibition.	Oxadiazoles	11-21	aldo-keto reductase family 1 member B	Homo sapiens	103-119	
27544072-1	2016	In continuation of our previous efforts directed towards the development of potent and selective inhibitors of aldose reductase (ALR2), and to control the diabetes mellitus (DM), a chronic metabolic disease, we synthesized novel coumarin-thiazole 6(a-o) and coumarin-oxadiazole 11(a-h) hybrids and screened for their inhibitory activity against aldose reductase (ALR2), for the selectivity against aldehyde reductase (ALR1).	Oxadiazoles	267-277	aldo-keto reductase family 1 member B	Homo sapiens	129-133	
27544072-9	2016	Hence, the results of this study revealed that coumarinyl thiazole and oxadiazole derivatives could act as potential ALR1/ALR2 inhibitors.	Oxadiazoles	71-81	aldo-keto reductase family 1 member B	Homo sapiens	122-126